Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 101–200 of 971
Corticotropin-Releasing Hormone
Taylor, A. L., & Fishman, L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807283190405 · Cited by 176
Rapid Analyte Recognition in a Device Based on Optical Sensors and the Olfactory System
White, J., Kauer, J. S., Dickinson, T. A., & Walt, D. R. (1996) · Analytical Chemistry · doi:10.1021/ac9511197 · Cited by 171
Costa, A., Trainer, P., Besser, M., & Grossman, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)91739-f · Cited by 174
LAMBERTS, S. W. J., VERLEUN, T., OOSTEROM, R., DE JONG, F., & HACKENG, W. H. L. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-58-2-298 · Cited by 168
Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., & Landgraf, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300040 · Cited by 168
“It is well established that AVP potently synergizes with CRH to stimulate pituitary ACTH secretion (von Bardeleben and Holsboer, 1989; Gillies et al, 1982).”
BackgroundKeck, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00351-7 · Cited by 167
“…was rapidly established that AVP potently synergizes with CRH to stimulate pituitary ACTH secretion: when CRH and AVP are co-administered, hormone output is well above the combined effects of the two neuropeptides in both humans (von Bardeleben and Holsboer 1985) and rodents (Gillies et al. 1982).”
BackgroundCloning and sequence analysis of cDNA for ovine corticotropin-releasing factor precursor
Furutani, Y., Morimoto, Y., Shibahara, S., Noda, M., Takahashi, H., Hirose, T., Asai, M., Inayama, S., Hayashida, H., Miyata, T., et al. (1983) · Nature · doi:10.1038/301537a0 · Cited by 170
The Paraventricular Nucleus of the Hypothalamus: Development, Function, and Human Diseases
Qin, C., Li, J., & Tang, K. (2018) · Endocrinology · doi:10.1210/en.2018-00453 · Cited by 162
The Endocrinology of the Opioids
Millan, M. J., & Herz, A. (1985) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60072-0 · Cited by 169
Hewagalamulage, S. D., Lee, T. K., Clarke, I. J., & Henry, B. A. (2016) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2016.03.004 · Cited by 167
Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat.
Davis, L. G., Arentzen, R., Reid, J. M., Manning, R. W., Wolfson, B., Lawrence, K. L., & Baldino, F. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.4.1145 · Cited by 168
Pang, S., Clark, A., Neto, E. C., Giugliani, R., Dean, H., Winter, J., Dhondt, J.-L., Farriaux, J. P., Graters, A., Cacciari, E., et al. (1993) · Screening · doi:10.1016/0925-6164(93)90024-d · Cited by 161
von Bardeleben, U., & Holsboer, F. (1989) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1989.tb00150.x · Cited by 161
“Several in vivo and in vitro studies have shown that AVP synergizes the effects of C R H at the pituitary level (30).”
BackgroundSakamoto, F., Yamada, S., & Ueta, Y. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2003.12.014 · Cited by 172
Legros, J.-J. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00018-x · Cited by 159
“The actions of VP and CRH are synergistic (Gillies et al., 1982).”
BackgroundHolsboer, F., Spengler, D., & Heuser, I. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)64586-0 · Cited by 159
Arnold, F. J. L., de Lucas Bueno, M., Shiers, H., Hancock, D. C., Evan, G. I., & Herbert, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90322-s · Cited by 155
Stress and central autonomic network
Lamotte, G. J., Shouman, K., & Benarroch, E. E. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102870 · Cited by 176
Bosch, O. J., Müsch, W., Bredewold, R., Slattery, D. A., & Neumann, I. D. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2006.12.012 · Cited by 172
“HPA axis activity, particularly ACTH secretion, is regulated through a synergistic action of hypothalamic CRH and AVP released from parvocellular neurones of the PVN (Gillies et al., 1982; Aguilera, 1994; Engelmann et al., 2004).”
BackgroundRIVIER, C., RIVIER, J., MORMEDE, P., & VALE, W. (1984) · Endocrinology · doi:10.1210/endo-115-3-882 · Cited by 154
Chronic stress plasticity in the hypothalamic paraventricular nucleus
Herman, J. P., Flak, J. N., & Jankord, R. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00429-9 · Cited by 166
“Vasopressin is implicated in amplification of pituitary ACTH secretion (Gillies et al., 1982).”
BackgroundWYNN, P. C., HARWOOD, J. P., CATT, K. J., & AGUILERA, G. (1985) · Endocrinology · doi:10.1210/endo-116-4-1653 · Cited by 153
Aguilera, G., Subburaju, S., YOUNG, S., & CHEN, J. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00403-2 · Cited by 168
“Being a weak stimulator on its own, VP can act as an important modulator of ACTH responses to stress by potentiating the stimulatory effect of the major regulator, corticotrophin releasing hormone (CRH) (Antoni et al., 1983; Buckingham, 1982; Gillies et al., 1982).”
BackgroundBRUHN, T. O., PLOTSKY, P. M., & VALE, W. W. (1984) · Endocrinology · doi:10.1210/endo-114-1-57 · Cited by 152
Sex, Stress, and Mood Disorders: At the Intersection of Adrenal and Gonadal Hormones
Fernández-Guasti, A., Fiedler, J., Herrera, L., & Handa, R. (2012) · Hormone and Metabolic Research · doi:10.1055/s-0032-1312592 · Cited by 144
Kelly, A. M., & Goodson, J. L. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.005 · Cited by 153
“Across the vertebrate taxa, VP derived from the PVN acts synergistically with corticotropin releasing hormone to stimulate secretion of adrenocorticotropic hormone, which in turn stimulates production of glucocorticoids in the adrenal cortex, or interrenal gland in anamniotes (Landgraf and Neumann, 2004; Baker et al.,…”
BackgroundDevelopment of the HPA axis: Where and when do sex differences manifest?
Panagiotakopoulos, L., & Neigh, G. N. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.002 · Cited by 162
“Studies have shown that AVP acts synergistically with CRF to stimulate ACTH secretion (Gillies et al., 1982), but has no effect in the absence of CRF on anterior corticotrophs (Lamberts et al., 1984).”
RIVIER, C. L., & Lee, S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00301-0 · Cited by 161
Reincke, M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.1.151 · Cited by 147
Herman, J. P., Cullinan, W. E., Young, E. A., Akil, H., & Watson, S. J. (1992) · Brain Research · doi:10.1016/0006-8993(92)91680-d · Cited by 161
New roles for estrogen receptor β in behavior and neuroendocrinology☆
Bodo, C., & Rissman, E. F. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.02.004 · Cited by 159
Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity
Holsboer, F. (1989) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00449812 · Cited by 159
Nagai, K., Nagai, N., Shimizu, K., Chun, S.-J., Nakagawa, H., & Niijima, A. (1996) · Progress in brain research · doi:10.1016/s0079-6123(08)60413-6 · Cited by 146
The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Ring, R. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382241 · Cited by 139
“Acting through vasopressinergic receptors expressed on adenohypophyseal corticotrophs, primarily of the V3R (V 1b) subtype, AVP acts synergistically with corticotropin releasing factor (CRF) to stimulate adrenocorticotropin hormone (ACTH) release from the anterior pituitary into the peripheral circulation.[39] Vasopre…”
BackgroundLYTRAS, N., GROSSMAN, A., PERRY, L., TOMLIN, S., WASS, J. A. H., COY, D. H., SCHALLY, A. V., REES, L. H., & BESSER, G. M. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00061.x · Cited by 142
Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH
Gagner, J.-P., & Drouin, J. (1985) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(85)90154-6 · Cited by 142
PLOTSKY, P. M., BRUHN, T. O., & VALE, W. (1985) · Endocrinology · doi:10.1210/endo-116-2-633 · Cited by 141
The Biological Clock: The Bodyguard of Temporal Homeostasis
Perreau-Lenz, S., Pévet, P., Buijs, R. M., & Kalsbeek, A. (2004) · Chronobiology International · doi:10.1081/cbi-120027984 · Cited by 132
“The stimulatory action of VP on ACTH and corticosterone release was definitely established in the early 1980s (Gillies et al., 1982; Rivier and Vale, 1983; Rivier et al., 1984).”
Backgroundβ‐Endorphin: Cytokine and Neuropeptide
Heijnen, C. J., Kavelaars, A., & BALLIEUX, R. E. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00577.x · Cited by 138
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation
Volpi, S., Rabadan-Diehl, C., & Aguilera, G. (2004) · Stress · doi:10.1080/10253890410001733535 · Cited by 136
“In humans and rodents, VP alone is a weak stimulus of ACTH secretion, but through its interaction with CRH it contributes to maintaining corticotroph responsiveness in spite of elevated glucocorticoid levels during chronic stress (Gilles et al., 1982; Antoni, 1993; Aguilera, 1994).”
BackgroundVasopressin and Copeptin in health and disease
Christ‐Crain, M. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09509-9 · Cited by 136
“A second AVP neurosecretory pathway transports high concentrations of the hormone from parvocellular neurons to the pituitary portal system where AVP acts synergistically with corticotropin-releasing hormone to stimulate adrenocorticotropic hormone (ACTH) release from the anterior pituitary [11, 12].”
BackgroundO’Keane, V., Frodl, T., & Dinan, T. G. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.03.009 · Cited by 140
“There is a consensus that the HPA activation in response to acute stress in rats is mediated through CRH activation (Jaferi and Bhatnagar, 2007; van Gaalen et al., 2002; Gillies et al., 1982).”
BackgroundZiegler, D. R. (2002) · Integrative and Comparative Biology · doi:10.1093/icb/42.3.541 · Cited by 127
“Notably, CRH and AVP have synergistic effects on pituitary ACTH release ( Gillies et al., 1982 ), and as such, AVP is thought of as an amplifier of the stress response.”
BackgroundGreidanus, T. B. V. W., van Ree, J. M., & de Wied, D. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90036-0 · Cited by 138
Corticotropin-Releasing Factor Modulates the Immune Response to Stress in the Rat*
JAIN, R., Zwickler, D., Hollander, C. S., BRAND, H., SAPERSTEIN, A., HUTCHINSON, B., Brown, C. A., & AUDHYA, T. K. (1991) · Endocrinology · doi:10.1210/endo-128-3-1329 · Cited by 141
Mezey, E., & Kiss, J. Z. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.245 · Cited by 129
Herman, J. P. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903630103 · Cited by 129
Newell-Price, J. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.176 · Cited by 129
“Vasopressin has a well documented synergistic effect with CRH for ACTH release (9, 23 , 24).”
BackgroundFrom Malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants
Pecoraro, N. C., Dallman, M. F., Warne, J. P., Ginsberg, A. B., Laugero, K. D., la Fleur, S. E., Houshyar, H., Gómez-Oliver, F., Bhargava, A., & Akana, S. F. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.07.004 · Cited by 144
Clinical Applications of Corticotropin-Releasing Factor
CHROUSOS, G. P., SCHUERMEYER, T. H., DOPPMAN, J., OLDFIELD, E. H., SCHULTE, H. M., GOLD, P. W., & LORIAUX, D. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-3-344 · Cited by 124
Love is more than just a kiss: a neurobiological perspective on love and affection
de Boer, A., van Buel, E. M., & Ter Horst, G. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.017 · Cited by 123
“The HPA axis is also under the influence of oxytocin nd vasopressin (Gillies et al., 1982; Rivier and Vale, 983; Legros, 2001).”
The vasopressin Avpr1b receptor: Molecular and pharmacological studies
Roper, J., O'Carroll, A.-M., Young, W., & Lolait, S. (2011) · Stress · doi:10.3109/10253890.2010.512376 · Cited by 117
“The impact of Avp in ACTH release is often regarded as ancillary to Crh as Avp alone is a weak ACTH secretagogue but together with Crh it acts synergistically to facilitate ACTH secretion (Gillies et al. 1982; Rivier and Vale 1983; Antoni 1993).”
BackgroundAtrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man
Kellner, M. B., Wiedemann, K., & Holsboer, F. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90543-x · Cited by 122
LINTON, E. A., TILDERS, F. J. H., HODGKINSON, S., BERKENBOSCH, F., VERMES, I., & LOWRY, P. J. (1985) · Endocrinology · doi:10.1210/endo-116-3-966 · Cited by 125
Self-citationFink, G., Robinson, I. C., & Tannahill, L. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017165 · Cited by 121
Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response
Baigent, S. (2001) · Peptides · doi:10.1016/s0196-9781(01)00395-3 · Cited by 146
Oxytocin as well as vasopressin potentiate ovine CRF in vitro
Antoni, F. A., Holmes, M. C., & Jones, M. T. (1983) · Peptides · doi:10.1016/0196-9781(83)90041-4 · Cited by 120
Aguilera, G., MILLAN, M. A., Hauger, R. L., & Catt, K. J. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24950.x · Cited by 119
Kasting, N. W. (1989) · Brain Research Reviews · doi:10.1016/0165-0173(89)90012-x · Cited by 127
Raadsheer, F. C., Sluiter, A. A., Ravid, R., Tilders, F. J. H., & Swaab, D. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91113-7 · Cited by 120
A Novel Type of Vasopressin Receptor on Anterior Pituitary Corticotrophs?*
BAERTSCHI, A. J., & FRIEDLI, M. (1985) · Endocrinology · doi:10.1210/endo-116-2-499 · Cited by 119
Hormonal and metabolic responses to exercise across time of day and menstrual cycle phase
Galliven, E. A., Singh, A., Michelson, D., Bina, S., Gold, P. W., & Deuster, P. A. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.6.1822 · Cited by 116
“Decreased adrenal responses in the AM compared with the PM have been reported in studies with other provocative tests of pituitary-adrenal function, including ovine CRH (oCRH) stimulation and insulin administration (10, 12, 18, 25, 31).”
ResultInfluentialThe Thymus-Adrenal Connection: Thymosin Has Corticotropin-Releasing Activity in Primates
Healy, D. L., Hodgen, G. D., Schulte, H. M., Chrousos, G. P., Loriaux, D. L., HALL, N. R. S., & Goldstein, A. L. (1983) · Science · doi:10.1126/science.6318312 · Cited by 116
The Hypothalamic-Pituitary-Adrenal Axis: A Brief History
Miller, W. L. (2018) · Hormone Research in Paediatrics · doi:10.1159/000487755 · Cited by 124
Hypothalamic Regulation of Corticotropin-Releasing Factor under Stress and Stress Resilience
Kageyama, K., Iwasaki, Y., & Daimon, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212242 · Cited by 137
Gal, C. S., Wagnon, J., Valette, G., Garcia, G., Pascal, M., Maffrand, J., & Fur, G. L. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39017-4 · Cited by 120
Chowdrey, H. S., Larsen, P. J., Harbuz, M. S., Jessop, D. S., Aguilera, G., Eckland, D. J. A., & Lightman, S. L. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15089.x · Cited by 118
Prenatal Treatment of Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Pang, S., Pollack, M. S., Marshall, R. N., & Immken, L. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220207 · Cited by 115
LINTON, E. A., BEHAN, D. P., SAPHIER, P. W., & LOWRY, P. J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1574 · Cited by 114
Self-citationAbou‐Samra, A., Catt, K. J., & Aguilera, G. (1986) · Endocrinology · doi:10.1210/endo-118-1-212 · Cited by 113
Warne, J. P. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.09.036 · Cited by 112
In the trout, CRH and AVT synergize to stimulate ACTH release
Baker, B. I., Bird, D. J., & Buckingham, J. C. (1996) · Regulatory Peptides · doi:10.1016/s0167-0115(96)00130-9 · Cited by 112
Gal, C. S.-L., Wagnon, J., Tonnerre, B., Roux, R., Garcia, G., Griebel, G., & Aulombard, A. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00035.x · Cited by 110
Itoi, K., Helmreich, D. L., Lopez-Figueroa, M. O., & Watson, S. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05464.1999 · Cited by 108
“CRH and AVP act synergistically on ACTH secretion in the anterior pituitary (Gillies et al., 1982).”
Prior stressor exposure primes the HPA axis
Johnson, J. D., O'Connor, K. A., Deak, T., Spencer, R. L., Watkins, L. R., & Maier, S. F. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00057-9 · Cited by 110
“AVP is a well known secretagogue that potentiates the ACTH releasing effect of CRH (Gillies et al., 1982).”
BackgroundVasopressin Boosts Placebo Analgesic Effects in Women: A Randomized Trial
Colloca, L., Pine, D. S., Ernst, M., Miller, F. G., & Grillon, C. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.019 · Cited by 109
“Vasopressin affects the hypothalamic–pituitary–adrenal (HPA) axis, inducing a sex-specific response in the secretion of cortisol (58).”
BackgroundGold, P. W., & Chrousos, G. P. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90080-0 · Cited by 109
Organization and Integration of the Endocrine System: The Arousal and Sleep Perspective
Chrousos, G. P. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.04.004 · Cited by 126
“[31–33] Furthermore, it appears that there is a positive reciprocal interaction between CRH and AVP at the level of the hypothalamus, with each neuropeptide stimulating the secretion of the other.”
BackgroundUth, R. M., McKelvy, J. F., Harrison, R. W., & Bohn, M. C. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490190404 · Cited by 107
Overview of cellular electrophysiological actions of vasopressin
Raggenbass, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.074 · Cited by 101
“Stress stimulates the release of vasopressin from neurons in the parvocellular division of the paraventricular nucleus into the pituitary portal circulation, where vasopressin potentiates the effect of corticotropin-releasing factor (CRF) on adrenocorticotropin hormone (ACTH) release (Gillies et al., 1982).”
BackgroundMüller, M. B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A. E., Keck, M. E., Zimmermann, S., Holsboer, F., & Wurst, W. (2000) · Endocrinology · doi:10.1210/endo.141.11.7767 · Cited by 99
Early life stress in epilepsy: A seizure precipitant and risk factor for epileptogenesis
van Campen, J. S., Jansen, F. E., Graan, P. N. E. D., Braun, K. P. J., & Joëls, M. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.09.029 · Cited by 114
“Through the pituitary portal veins, these hormones reach the anterior pituitary where CRH stimulates the synthesis and secretion of adrenocorticotropic hormone (ACTH), a process potentiated by AVP [44].”
BackgroundInteraction among Social Environment, the Hypothalamic–Pituitary–Adrenal Axis, and Behavior
DeVries, A. C. (2002) · Hormones and Behavior · doi:10.1006/hbeh.2002.1780 · Cited by 115
Schulte, H. M., Chrousos, G. P., Gold, P. W., Booth, J. D., Oldfield, E. H., Cutler, G. B., & Loriaux, D. L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111890 · Cited by 103
“Weasked three questions: (1) Is the circadian rhythm of ACTHand cortisol abolished during continuous CRFstimulation of the corticotroph, as expected, or is it preserved (2)? Does the increase in the magnitude of ACTH and cortisol during continuous CRF administration resemble that seen during stress, Cushing's disease,…”
BackgroundMethodInfluentialYoung, 3., & Gainer, H. (2003) · Neuroendocrinology · doi:10.1159/000073702 · Cited by 103
RITTMASTER, R. S., CUTLER, G. B., SOBEL, D. O., GOLDSTEIN, D. S., KOPPELMAN, M. C. S., LORIAUX, D. L., & CHROUSOS, G. P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-5-891 · Cited by 102
Chapter II Neurobiology and neuropathology of the human hypothalamus
Swaab, D. F. (1997) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(97)80004-8 · Cited by 113
The role of adrenal gland microenvironment in the HPA axis function and dysfunction during sepsis
Kanczkowski, W., Sue, M., Zacharowski, K., Reincke, M., & Bornstein, S. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.12.019 · Cited by 101
Childhood Abuse and Migraine: Epidemiology, Sex Differences, and Potential Mechanisms
Tietjen, G. E., & Peterlin, B. L. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01906.x · Cited by 99
Cross-Reactive Metal Ion Sensor Array in a Micro Titer Plate Format
Mayr, T., Igel, C., Liebsch, G., Klimant, I., & Wolfbeis, O. S. (2003) · Analytical Chemistry · doi:10.1021/ac020774t · Cited by 101
Oxytocin potentiates the ACTH-releasing activity of CRF(41) but not vasopressin
Gibbs, D. M., Vale, W., Rivier, J., & Yen, S. S. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90212-1 · Cited by 101
Schmidt, E. D., Binnekade, R., Janszen, A. W. J. W., & Tilders, F. J. H. (1996) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1996.05106.x · Cited by 101
El-Kabir, D. R., Wyatt, M. E., Vellucci, S. V., & Herbert, J. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90018-r · Cited by 104
Herman, J. P., Schäfer, M. K.-H., Sladek, C. D., Day, R. W., Young, E. A., Akil, H., & Watson, S. J. (1989) · Brain Research · doi:10.1016/0006-8993(89)90641-0 · Cited by 100
Case histories of peptidomimetics: Progression from peptides to drugs
Adang, A. E. P., Hermkens, P. H. H., Linders, J. T. M., Ottenheijm, H. C. J., & van Staveren, C. J. (1994) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19941130202 · Cited by 100
Zuloaga, D. G., Heck, A. L., De Guzman, R. M., & Handa, R. J. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00319-2 · Cited by 90
Walker, C.-D., Deschamps, S., Proulx, K., Tu, M., Salzman, C., Woodside, B., Lupien, S., Gallo-Payet, N., & Richard, D. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0436 · Cited by 99
Tonon, M. C., Cuet, P., LAMACZ, M., Jégou, S., Côté, J., Gouteux, L., LING, N. C., Pelletier, G., & Vaudry, H. (1986) · General and Comparative Endocrinology · doi:10.1016/0016-6480(86)90231-5 · Cited by 99
Korbonits, M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2489 · Cited by 97
“viously described synergistic phenomenon (31, 33).”
Background
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.